StockData
Spruce Biosciences, Inc. logo

Spruce Biosciences, Inc. (SPRB) bonds

SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$40.49−1.76 (-4.17%)

Close on Nov 17, 2026Market cap $116.37MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$7.09M
$2.50M due within a year
Net debt
-$89.20M
After $96.30M of cash
Implied interest rate
10.31%
FY2025 interest ÷ average debt
Interest coverage
-405.7×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2024

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Spruce Biosciences's 10-Q for the period ended Jul 1, 2026

IssueCouponAmount issuedCarrying value
After the first anniversary2.00%––
After the second anniversary4.00%––
Avenue Loan
Convertible at $60 a share
––$7.10M
Prior to the first anniversary3.00%––
Prior to the second anniversary1.00%––
Tranche 1–$15.00M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Second Tranche Term Loan$10.00M

See a number that looks wrong?